Experimental Data Interpretation

As academics, we all want our research to be trusted, reproducible, and strong enough to withstand review. Yet most of the problems we face during publication come from one place: weak statistical foundations and unclear experimental design. This is why I want to give you a quick, practical guide you can use to strengthen any study you are planning or refining. These principles are simple, but they prevent the most common errors I see across manuscripts, reviews, and collaborations. 1. Statistics is not about numbers. It is about reasoning. Each test, each calculation, tells a story about your data and what it truly means. 2. Experimental design begins with purpose. Define your objective clearly before you begin collecting data. The design should flow naturally from the research question. 3. Randomization protects integrity. Assign treatments randomly to eliminate bias and ensure valid comparisons. 4. Replication increases confidence. Repeating experiments strengthens conclusions and helps distinguish real effects from noise. 5. Control groups matter. They provide the baseline that gives your results meaning. Without controls, interpretation becomes speculation. 6. Choose tests based on data, not habit. Understand whether your variables are categorical, continuous, or ordinal. Then select the statistical method that fits the data, not the one that feels familiar. 7. Interpret, do not just report. Numbers are not the end of the story. Explain what they mean, why they matter, and how they support or challenge your hypothesis. 8. Visuals clarify understanding. Use tables and graphs to reveal patterns and relationships, but keep them clean, accurate, and purposeful. 9. Ethical analysis is non-negotiable. Never manipulate data to fit a narrative. Transparency and honesty sustain the credibility of your research. 10. Statistics and design are partners. Good design minimizes errors. Good statistics reveal the truth within them. One without the other cannot stand. These principles are not theoretical. They are the difference between a study that moves quickly through review and a study that struggles with rejection, uncertainty, or inconsistent conclusions. Download the full PDF below. Do you think your current research would benefit from this guide? Reply and tell me. I would love to know. ______________________________ 📌 This is Prof. Samira Hosseini. I’ve helped 12,000+ ambitious academics go from struggling with publishing papers in Q1 journals, limited visibility, and poor citation records to building a solid research trajectory and high 𝘩-index. Book a free Strategy Call, and we can dive into your challenges in top-tier journal publication and citation and see how I can best assist you: https://lnkd.in/ezqV64dX

1/ Bioinformatics isn't just code. It’s intuition. You run the stats, but you feel when something’s wrong. That feeling is a clue. 2/ One outlier can break your whole analysis. Like this plot: the trend looks strong— Until you see 1 point pulling the line. 3/ That’s why I say: Look at your data. Print the rows. Plot the points. Stare at it like it’s hiding something. Because it often is. 4/ Correlation? An outlier can fake a perfect r = 0.9. Remove it—and your story disappears. Plot before you publish. 5/ Exploratory Data Analysis (EDA) isn’t extra. It’s survival. Boxplots. Histograms. PCA. Use them all. 6/ For genomics: Never trust variant calls blindly. Fire up IGV. Zoom into those BAM files. What looks like a somatic mutation may be a mapping mess. 7/ In ChIP-seq, visualize peaks on a genome browser. Off-target antibodies? Duplicate artifacts? Black-listed regions? They all look different in IGV. 8/ We’ve seen this before: The datasaurus. 12 datasets, same summary stats. But one’s a T-rex. https://lnkd.in/eetYBNai 9/ Or the paper where researchers missed a gorilla in the data. https://lnkd.in/eY-5DgeG They did not see it because they did not plot it 10/ Plotting isn’t just for pretty figures. It’s how you find the story. Or find the mistake before your reviewer does. 11/ Look at: distribution of read counts % mito reads fragment length batch effects in PCA sample swaps in clustering 12/ My rule: If something surprises you, don’t move on. Go back. Plot it again. Chances are, it’s not a surprise—it’s a clue. 13/ EDA saves time. It saves embarrassment. And it makes you a better scientist, not just a better coder. 14/ Key takeaways: Trust your gut when something feels off Visualize before and after every major step Use IGV, PCA, boxplots, histograms Don’t assume—check 15/ Bioinformatics isn’t clean. It’s messy, human, flawed. But when you see the data, you see the truth. That’s where real insight begins. I hope you've found this post helpful. Follow me for more. Subscribe to my FREE newsletter chatomics to learn bioinformatics https://lnkd.in/erw83Svn

Struggles of doing data science in the real world 🤦: What do you do when there’s no A/B test but you still need insights? I recently faced that challenge (again): 👉 The growth team asked me to evaluate the impact of a new mobile app feature on conversions (a week after it launched) In the real world, data is messy, and A/B tests aren’t always an option. As a Data Scientist, you need to learn to be resourceful Here’s how I approached it: 1️⃣ Segmented analysis: I created pre- and post-launch groups based on user signup dates. 2️⃣ Exploratory data analysis (EDA): Visualized conversion trends, layering in cohort and seasonal comparisons. 3️⃣ Statistical testing: Ran an independent t-test to validate observed changes, carefully checking assumptions like normality and variance equality. Result? A clear signal of increased conversions on iOS, while Android showed minimal impact. 💡 Key takeaway: T-tests (or similar methods) can still deliver actionable insights outside traditional A/B testing, but validating assumptions and adding context is critical to making reliable conclusions. I broke down my full workflow and the lessons learned in my latest newsletter article (If you’re curious, check the link in the comments👇) What’s your go-to method for analyzing feature impacts without a perfect experimental setup?

What MS/MS-based quantitative proteomics data can — and cannot — tell you 😎 Biologists who send samples to Proteomics Facilities often expect proteomics to “explain everything”: reveal all pathway changes, identify key drivers of a phenotype, and map molecular mechanisms. 🧐 This expectation is not aligned with how the technology works. Mass-spectrometry–based quantitative proteomics is sensitive and highly informative, but it has strict experimental and analytical limits. 🧑🔬 What you can reliably extract from proteomics: • Relative changes in protein abundance between experimental conditions, assuming proper normalization and replication. • True biological variability — whether an observed effect is consistent across replicates or dominated by statistical noise. • Candidate proteins worth validating with orthogonal methods. • Whether proteins belonging to known pathways are up- or down-regulated (hypothesis-generating, not mechanism-defining). 🫣 What you cannot extract without targeted design, controls, or additional assays: • Absolute protein concentrations — these require calibrated standards or spike-ins. • Complete proteome coverage — detection is biased by abundance, ionization efficiency, digestion efficiency, and peptide detectability. • Mechanistic pathway conclusions from enrichment — enrichment reflects statistical associations, not causality. We also rely on biological knowledge databases, which are incomplete and not uniformly curated. • Post-translational modifications by default — you only detect PTMs explicitly included in the search, and only if modified peptides are detectable. In most cases, enrichment is required to see them properly. Making the story short: Quantitative proteomics provides powerful functional insight, but only within the objective boundaries of the technology: it gives you the relative abundance of detected proteins. Nothing less and nothing more. Understanding these boundaries upfront makes experimental design stronger, analysis more reliable, and biological interpretation more grounded. 🌱 #proteomics #massspectrometry #LCMSMS #quantitativeproteomics #bioinformatics #systemsbiology #experimentaldesign #omics #datainterpretation #dataanalysis #biology

#Free RNA-Seq #Tutorial: Why Your DESeq2 Results Are Wrong (And How to Fix It in 30 Minutes) — Here's an uncomfortable truth: most published RNA-seq studies skip the one step that catches their biggest errors. That step is Exploratory Data Analysis (EDA). And every reproducibility crisis I've seen in transcriptomics traces back to it. 🧬 Session 06: Exploratory Data Analysis Before DESeq2 — Now Live (Free) If you've ever: 🔹 Found a beautiful DE gene list that wouldn't replicate 🔹 Discovered a sample swap after publication 🔹 Wondered why your batch effect "disappeared" with normalization 🔹 Wasted weeks chasing artifacts that EDA would have caught in 30 minutes This tutorial is for you. What you'll learn (free, no signup, no paywall): ✅ VST vs rlog transformations — when to use each (and why neither goes into DESeq2) ✅ PCA interpretation that actually makes sense — what PC1 and PC2 really tell you, with real brain RNA-seq examples ✅ Detecting batch effects before they ruin your analysis — the visual signatures every bioinformatician should recognize ✅ Sample distance matrices and hierarchical clustering — catch mislabelled samples and swaps in 5 minutes ✅ The pre-DESeq2 checklist — 10 verification steps before running a single contrast ✅ Brain-specific EDA pitfalls — why sex often dominates PC1, how cell-type shifts mimic batch effects, and when an "outlier" is actually a rare diagnosis (C9orf72, Lewy body co-pathology) The 30-minute rule: Every unexpected finding in your final paper should have been visible in your EDA. If it wasn't, your EDA was incomplete. Real examples covered: ▸ How a sex effect on PC1 looks vs a disease effect ▸ Why PsychENCODE samples cluster by brain bank before disease ▸ The PCA pattern that means "you have a sample swap" ▸ When to exclude a sample vs when to include it as a covariate 🔗 Free access: https://lnkd.in/eyYf3hFU 👇 What's the worst EDA mistake you've ever caught (or missed)? Drop it in the comments — the best stories will be featured in Session 07. Save this post for your next RNA-seq analysis. 📌 #RNASeq #DESeq2 #Bioinformatics #ExploratoryDataAnalysis #PCA #ComputationalBiology #Transcriptomics #DataScience #Genomics #BatchEffects #ReproducibleResearch #OpenScience #FreeTutorial #LearnBioinformatics #PhDLife #PostdocLife #Neurogenomics #PrecisionMedicine #MolecularBiology #SystemsBiology #Multiomics #MultiomeAcademy #Rstats #PythonForBiology #AcademicLinkedIn #DataAnalysis #Biostatistics #ScienceCommunication #LifeSciences #Biotech

🚀 A Life-Changing Lesson I Learned at Google — That Every Analyst Needs to Hear At Google, I learned the fastest way to generate impact isn't writing code. It's mastering conceptual reasoning before you touch a tool. Let's take Exploratory Data Analysis (EDA). 🙅♀️ Most analysts treat it as a technical race. A checklist of commands to run. 💡 But EDA isn't a coding competition. It's a framework for thinking. It’s not about the commands you run; it’s about the questions you ask. Here’s the framework we used 👇 Notice how the "So What?" is built in from the very beginning. 1. Find the Shape (Observe, Don't Analyze) Before you run a single command, get the 30,000-foot view. Ask: What's the scale (thousands or millions)? What are the extremes? Is the data skewed by a few massive values? Purpose: To understand the landscape before you get lost in the details. 2. Understand the Components (Univariate) Now, zoom in on one variable at a time. Ask: How is this metric distributed? Is it stable, volatile, or clustered? Are outliers mistakes, or are they your most valuable insights? Purpose: To understand the behavior of each individual character in the story. 3. Connect the Dots (Bivariate) Step back and see how the characters interact. Ask: When one metric goes up, what does another do? Which relationships are worth paying attention to — and which are noise? Are you seeing signs of dependency (e.g., engagement rises, then conversions follow)? Purpose: To identify potential cause-and-effect patterns—not to prove them, but to know where to look deeper. 4. Add Context (Time & Segments) Data doesn't exist in a vacuum. Ask: How has this changed over time? What's driving it (seasonality, a product launch)? Which segments (geographies, demographics) behave differently? Purpose: To connect abstract patterns to real-world business decisions. 5. Deliver the "So What" (The Decision) This is the only step that matters. An analysis is useless until it forces a decision. Ask: What does this mean for the business? What should we do next? Purpose: To move from description ("what")->>> interpretation ("so what") ->>> action ("now what"). 💬 The Takeaway: You don’t need a complex tool to master analytics. You need to learn how to observe, connect, and reason. Tools can compute. Analysts must interpret. Comment 👍 if you need my full EDA framework guide

How Knowledge Graphs Are Really Built #4 The Hidden Relationships in the Lab Data There are millions of public genomic profiles and your lab generates thousands of data points daily. Are you capturing the relationships between them? Experimental data is your most valuable knowledge source. It's also the hardest to turn into a knowledge graph. Why Experimental Data is Different Unlike databases with explicit relationships or literature with stated facts, experimental data requires interpretation. You infer that compound A inhibits target B from IC50 values, statistical significance, and experimental conditions. This is both the challenge and the opportunity. Your experimental data contains relationships no one else has. The Types of Experimental Data High-throughput screening generates activity profiles across thousands of compounds and assays. Each data point is a potential relationship: compound X tested in assay Y with result Z under conditions W. Omics data reveals molecular networks. Genomics shows which genes are mutated together. Proteomics identifies co-expressed proteins. Metabolomics maps metabolic pathway changes. Clinical trial data links interventions to patient outcomes over time. Treatment regimens to response rates. Biomarkers to adverse events. Public databases like GEO multiply this value. Integrate your internal data with these resources and new patterns emerge. The Critical Challenges Variability and batch effects plague experimental data. Combining data requires normalization, but your choices affect the relationships you derive. Metadata harmonization is notoriously challenging. Different studies often name the same clinical variables and their values differently. Then comes the hard question: what relationships do you want to calculate? From the same omics data, you can calculate gene-gene relations or gene-disease relations. The method you choose also fundamentally shapes your knowledge graph. How do you benchmark these methods? Building the Graph Link experimental conditions to outcomes explicitly. Don't just store that compound X had IC50 of 5nM. Capture the pH, solvent, incubation time. These become queryable properties. Create entity relationships thoughtfully. Now you can ask: "Show me all compounds active in target X assays, tested in the same cell line as our lead compound, with reproducible results across batches." Temporal relationships matter in longitudinal studies and often reveal causality. Reproducibility and Traceability Every relationship should trace back to source data. Which experiment? Which plate? Inferring confidence levels for every relation is essential for usability. Version your data and analysis methods. What experimental data do you wish you could query more effectively?